Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - OtherWages, Salaries and Other
Ratios

Bicycle Therapeutics (BCYC) Receivables - Other (2019 - 2025)

Bicycle Therapeutics' Receivables - Other history spans 7 years, with the latest figure at $35.6 million for Q4 2025.

  • For Q4 2025, Receivables - Other changed 0.15% year-over-year to $35.6 million; the TTM value through Dec 2025 reached $35.6 million, changed 0.15%, while the annual FY2025 figure was $35.6 million, 0.15% changed from the prior year.
  • Receivables - Other reached $35.6 million in Q4 2025 per BCYC's latest filing, down from $67.3 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $67.3 million in Q3 2025 to a low of $7.7 million in Q3 2021.
  • Average Receivables - Other over 5 years is $30.7 million, with a median of $25.3 million recorded in 2023.
  • Peak YoY movement for Receivables - Other: dropped 20.81% in 2023, then surged 260.47% in 2024.
  • A 5-year view of Receivables - Other shows it stood at $7.7 million in 2021, then surged by 148.73% to $19.2 million in 2022, then increased by 25.45% to $24.0 million in 2023, then skyrocketed by 48.31% to $35.7 million in 2024, then decreased by 0.15% to $35.6 million in 2025.
  • Per Business Quant, the three most recent readings for BCYC's Receivables - Other are $35.6 million (Q4 2025), $67.3 million (Q3 2025), and $60.8 million (Q2 2025).